Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05015478 · ClinicalTrials.gov registry record · NA
Rhythmic Light Therapy for Alzheimer's Disease Patients
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT05015478 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 52 participants.
The verdict
NCT05015478, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The investigator will investigate how light delivering 40 hertz (Hz) affects subjective sleep and cognition in a controlled laboratory study. A lab study will allow the collection of electroencephalogram (EEG) data, perform cognitive tests, and observe the response in those with mild cognitive impairment (MCI) compared to a healthy control group (HC). Participants will attend two study sessions over the course of two weeks. During both sessions, all participants will experience 10 minutes of a low-level light, followed by a data collection period which involves a sleepiness rating, an electroencephalogram (EEG) recording, and a computerized memory test. Participants will then experience either a RL or a placebo RL condition for one hour, after which there will be a second data collection.
Interventions
- DEVICE Tailored Rhythmic Lighting Intervention
- DEVICE Placebo Rhythmic Lighting Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2022-01-10 |
| Est. Completion | 2023-09-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05015478
The ClinicalTrials.gov registry entry for NCT05015478 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tailored Rhythmic Lighting Intervention is the first listed.
NCT05015478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05015478 about?
NCT05015478 is a clinical study titled "Rhythmic Light Therapy for Alzheimer's Disease Patients". The investigator will investigate how light delivering 40 hertz (Hz) affects subjective sleep and cognition in a controlled laboratory study. A lab study will allow the collection of electroencephalogram (EEG) data, perform cognitive tests, and observe the response in those with mild cognitive impai...
What is the current status of trial NCT05015478?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2022-01-10. Estimated completion is 2023-09-12.
What interventions are being tested in trial NCT05015478?
The interventions under investigation include: Tailored Rhythmic Lighting Intervention (DEVICE), Placebo Rhythmic Lighting Intervention (DEVICE).
Who is sponsoring clinical trial NCT05015478?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.